Leonard Sank, Director at ORAMED PHARMACEUTICALS INC. (ORMP), bought 22,840 shares at $0.30 ($7K) on 2008-01-07, disclosed to the SEC on 2008-01-09.
Open-market purchase of $7k ORMP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ORMP | BUY | 2019-07-15 | $4K | — | Filing → |
| ORMP.OB | BUY | 2011-10-06 | $300K | — | Filing → |
| ORMP | BUY | 2008-01-17 | $5K | — | Filing → |